- Home
- AGAE vs NTRB Comparison
AGAE vs NTRB Comparison
Compare AGAE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.43
HOLD
Current Price
$4.48
Company Overview
Basic Information| Metric | AGAE | NTRB |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Industrial Specialties |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 57.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AGAE | NTRB |
|---|---|---|
| Price | $0.43 | $4.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 1.3M | 65.5K |
| Earning Date | 11-19-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,938,232.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $0.34 | $3.90 |
| 52 Week High | $3.79 | $11.78 |
Technical Indicators
Market Signals| Indicator | AGAE | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 52.27 | 41.18 |
| Support Level | $0.39 | $4.34 |
| Resistance Level | $0.49 | $6.41 |
| Average True Range (ATR) | 0.04 | 0.45 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 56.88 | 2.40 |
Price Performance
Historical Comparison AGAE
NTRB
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.